Meningitis News and Research

Latest Meningitis News and Research

Dangers of not vaccinating children

Deadly diseases are making a comeback. Pertussis, or whooping cough, has killed nine infants this year in California, and outbreaks of measles and Hib meningitis have struck U.S. communities in the past three years.

5 Oct 2010

$3.4M grant for study to distinguish bacterial infections from viral infections in infants with fevers

Octavio Ramilo, MD, chief of Infectious Diseases at Nationwide Children's Hospital, is one of three principal investigators who will share in a five-year, $3.4 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Dr. Ramilo and a team of more than 50 physicians across the United States are investigating the use of novel technologies for distinguishing between bacterial and viral infections in infants with fevers within emergency departments.

4 Oct 2010

Advances in treatment and management of neurological disorders

The latest advances in treating neurologic disorders such as stroke, headache, Parkinson's disease, epilepsy and sleep disorders are detailed in a special issue of the journal Neurologic Clinics.

4 Oct 2010

Neurologic Clinics journal publishes latest advances in neurologic disorders

The latest advances in treating neurologic disorders such as stroke, headache, Parkinson's disease, epilepsy and sleep disorders are detailed in a special issue of the journal Neurologic Clinics.

1 Oct 2010

Research shows dexamethasone treatment effective for bacterial meningitis

New research shows that an intravenous (IV) treatment may cut a person's risk of dying from bacterial meningitis. The research is published in the September 29, 2010, online issue of Neurology, the medical journal of the American Academy of Neurology. The treatment is called dexamethasone.

30 Sep 2010

Outbreak of whooping cough mirrors challenges in developing world, global health official says

The outbreak of whooping cough in Texas, California, and other states this year underscores the critical importance of widespread vaccination coverage, both locally as well as around the world, said a leading global health official attending conferences on world affairs and immunization in Fort Worth this week.

29 Sep 2010

GBS pathogen suppresses immune cell function in newborn infants: Research

Group B Streptococcus (GBS), a bacterial pathogen that causes sepsis and meningitis in newborn infants, is able to shut down immune cell function in order to promote its own survival, according to researchers at the University of California, San Diego School of Medicine and the Skaggs School of Pharmacy and Pharmaceutical Sciences.

27 Sep 2010

Eastmont Community Center launches new adolescent immunization awareness initiative

Eastmont Community Center responded today to alarmingly low whooping cough and meningococcal meningitis immunization rates among Latino adolescents by launching a new adolescent immunization awareness initiative. The grassroots campaign aims to educate local Latino families about free or low-cost vaccines available to help protect children against these and other infectious diseases.

24 Sep 2010

Immunization is critical to reduce child deaths

Immunising children against preventable diseases is critical to achieving United Nations-led goals to reduce child deaths, global health and development chiefs said in New York today.

22 Sep 2010

NICE clinical guideline for bacterial meningitis and meningococcal septicaemia in children

Every parent knows the story and every parent dreads it. You take a feverish child to the doctors, you know something isn't right; but you are just sent back home with advice about paracetamol. Hours later the child is admitted to hospital with meningitis.

14 Sep 2010

395 new vaccines being developed for infectious diseases: PhRMA

Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America's biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning in clinical trials or under Food and Drug Administration (FDA) review.

10 Sep 2010

FDA accepts Sanofi Pasteur's Menactra vaccine sBLA for active immunization of infants and toddlers

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.

26 Aug 2010

Pathogens can delay entry into cells to ensure their survival, say researchers

Pathogens make themselves feel at home in the human body, invading cells and living off the plentiful amenities on offer. However, researchers at the Max Planck Institute for Infection Biology, Berlin, together with colleagues at Harvard University, reveal an opposite strategy used to ensure infection success. Pathogens can actually delay their entry into cells to ensure their survival.

26 Aug 2010

Improvement in mumps vaccine administration needed to prevent future outbreaks

Although immunity to mumps is high in the United States, mumps vaccine coverage must be maintained and improved to prevent future outbreaks, according to a new study, now available online (http://www.journals.uchicago.edu/doi/full/10.1086/655394), in the September 1, 2010 issue of The Journal of Infectious Diseases.

25 Aug 2010

Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalification

The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.

24 Aug 2010

Immunization rate increases among teens: NIS report

In light of today's report of the National Immunization Survey results, the Society for Adolescent Health and Medicine (SAHM) encourages increased efforts in fully immunizing all adolescents.

21 Aug 2010

FDA approves CSL Behring's sBLA to extend shelf life of Hizentra from 18 to 24 months

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life of Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, from 18 months to 24 months. Hizentra, the first and only 20 percent subcutaneous immunoglobulin (SCIg) approved in the U.S. by the FDA, is also the first and only SCIg in the U.S. that may be stored at room temperature.

19 Aug 2010

Rush University Medical Center tests new drug therapy for West Nile fever

Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West Nile virus. Rush is the only site in the Midwest enrolling patients into the $50 million dollar, NIH-funded, Phase II clinical trial called PARADIGM.

18 Aug 2010

NASN encourages parents to vaccinate their children against meningococcal disease

More than half of adolescents 13 to 17 years of age have not been vaccinated against meningococcal disease, a rare but serious disease that can cause meningitis and take the life of a child in just a single day. In a recent Ipsos national survey, the majority of mothers with children in this age group had not vaccinated their children because they were not fully aware of the need for vaccination.

18 Aug 2010

Scientists develop rapid diagnostic test for detecting meningococcal bacteria

Researchers at Queen's University Belfast and the Belfast Health and Social Care Trust have developed a groundbreaking test for meningitis which could help save lives.A rapid diagnostic test for meningococcal bacteria that can produce results within an hour has been developed by scientists from Queen's Centre for Infection and Immunity and the Trust. The speed of this new test is a vital factor in the treatment of young children with meningococcal meningitis and septicaemia who become very ill over a short period.

18 Aug 2010

Meningitis News and Research

Latest Meningitis News and Research

Dangers of not vaccinating children

$3.4M grant for study to distinguish bacterial infections from viral infections in infants with fevers

Advances in treatment and management of neurological disorders

Neurologic Clinics journal publishes latest advances in neurologic disorders

Research shows dexamethasone treatment effective for bacterial meningitis

Outbreak of whooping cough mirrors challenges in developing world, global health official says

GBS pathogen suppresses immune cell function in newborn infants: Research

Eastmont Community Center launches new adolescent immunization awareness initiative

Immunization is critical to reduce child deaths

NICE clinical guideline for bacterial meningitis and meningococcal septicaemia in children

395 new vaccines being developed for infectious diseases: PhRMA

FDA accepts Sanofi Pasteur's Menactra vaccine sBLA for active immunization of infants and toddlers

Pathogens can delay entry into cells to ensure their survival, say researchers

Improvement in mumps vaccine administration needed to prevent future outbreaks

Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalification

Immunization rate increases among teens: NIS report

FDA approves CSL Behring's sBLA to extend shelf life of Hizentra from 18 to 24 months

Rush University Medical Center tests new drug therapy for West Nile fever

NASN encourages parents to vaccinate their children against meningococcal disease

Scientists develop rapid diagnostic test for detecting meningococcal bacteria

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Meningitis News and Research

Latest Meningitis News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in